Cellectar Biosciences Inc (CLRB)
3.33
-0.03
(-0.89%)
USD |
NASDAQ |
May 16, 16:00
3.33
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2010 | 0.0083M |
| December 31, 2009 | 0.0193M |
| September 30, 2009 | 0.0137M |
| June 30, 2009 | 0.0323M |
| March 31, 2009 | 0.031M |
| December 31, 2008 | 0.0364M |
| September 30, 2008 | 0.0355M |
| June 30, 2008 | 0.0457M |
| March 31, 2008 | 0.0083M |
| December 31, 2007 |
| Date | Value |
|---|---|
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | |
| March 31, 2006 | |
| December 31, 2005 | |
| September 30, 2005 | 0.0126M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -5.239M |
| Eli Lilly and Co | 8.768B |
| Actinium Pharmaceuticals Inc | -- |
| Bristol-Myers Squibb Co | 11.86B |
| Altimmune Inc | 0.005M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.58M |
| Total Expenses (Quarterly) | 12.00M |
| EPS Diluted (Quarterly) | -0.74 |
| Enterprise Value | 96.42M |
| Earnings Yield | -92.49% |